Article

Genetic variation in apolipoprotein A-I concentrations and risk of coronary artery disease

2019-03-15

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Rationale</h4> Apolipoprotein A-I (apoA-I) infusions represent a potential novel therapeutic approach for the prevention of coronary artery disease (CAD) with phase III cardiovascular outcome trials currently underway. Although circulating apoA-I levels inversely associate with risk of CAD, the evidence base of this representing a causal relationship is lacking. <h4>Objective</h4> To asses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e1ae24fd-4417-5231-bf93-c2744ddf8f0e
DOI: 10.1101/576504

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic variation in apolipoprotein A-I concentrations and risk of coronary artery diseaseDOI 10.1101/576504Read

Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study.Semantic proximity Read

Polygenic modulation of lipoprotein(a)-associated cardiovascular riskSemantic proximity Read

No genetic evidence for an association of apolipoprotein A-I with cardiovascular outcomes at different LDL cholesterol levels: drug-target Mendelian randomization analyses.Semantic proximity Read

The Causal Role of Apolipoprotein B/A1 Ratio in Coronary Heart Disease and Ischemic Stroke: A Mendelian Randomization StudySemantic proximity Read

Genetics-Current and Future Role in the Prevention and Management of Coronary Artery Disease.Semantic proximity Read

High-density lipoprotein characteristics and coronary heart disease: a Mendelian randomization studySemantic proximity Read

Assessing dose-response relations of lipid traits with coronary artery disease, all-cause mortality, and cause-specific mortality: a linear and non-linear Mendelian randomization studySemantic proximity Read

Mendelian Randomization Analysis of Hemoglobin A1c as a Risk Factor for Coronary Artery DiseaseSemantic proximity Read

<i>Cis</i> -epistasis at the <i>LPA</i> locus and risk of coronary artery diseaseSemantic proximity Read

The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.Semantic proximity Read

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.Semantic proximity Read

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.Semantic proximity Read